In this research paper, I explored the potential of PGK1 (Phosphoglycerate Kinase 1) as a promising cancer therapeutic. As a pharmacist deeply invested in oncology research, my work delved into the intricate molecular mechanisms underlying PGK1's role in cancer progression. I meticulously examined existing scientific literature, dissecting cellular pathways and highlighting the therapeutic potential of targeting PGK1 in cancer treatment. Through a blend of comprehensive research and precise articulation, the paper contributes valuable insights to the evolving landscape of cancer therapeutics, emphasizing the significance of PGK1 as a potential target for innovative and targeted anticancer strategies.
